MedPath
NMPA Approval

Leflunomide Tablets

国药准字HJ20240075

July 30, 2024

Drug Information

来氟米特片

片剂

20mg

化学药品

July 30, 2024

July 29, 2029

Company Information

Applicant Company

PLOT NO. P1 AND P2, I.T.B.T. PARK PHASE-II, M.I.D.C. HINJAWADI PUNE 411057 MAHARASHTRA STATE, INDIA

Manufacturing Company

PLOT NO.P1 AND P2,I.T.B.T. PARK PHASE-II, M.I.D.C. HINJAWADI PUNE 411057 MAHARASHTRA STATE, INDIA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

来氟米特片 - NMPA 批准文号 | MedPath